RANOLAZINE

Product NDC: 71610-322
Requested package NDC: 71610-322-83
11-digit product format: 716100322
Labeler code: 71610
Product ID: 71610-322_ebab2e5e-06e9-4d86-a335-cf9d48b2e9ed
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: RANOLAZINE
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Labeler: Aphena Pharma Solutions - Tennessee, LLC
Application: ANDA211829
Marketing category: ANDA
Marketing start: 2019-06-04
Marketing end: 0000-00-00
Substance: RANOLAZINE
Active strength: 500 mg/1
Pharmacologic classes: Anti-anginal [EPC],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	71610-322	71610-322-83	I	Inactivated by FDA		2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 15 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A211829-001	RANOLAZINE	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB		2019-06-04
A211829-002	RANOLAZINE	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB		2019-06-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A211829-001	AB
A211829-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A211829-001	RANOLAZINE	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A211829-002	RANOLAZINE	1GM	TABLET, EXTENDED RELEASE / ORAL	AB	2019-06-04	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A211829-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A211829-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A211829-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A211829-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A211829-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A211829-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A211829-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A211829-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A211829-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A211829-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A211829-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A211829-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A211829-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A211829-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A211829-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A211829-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A211829-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A211829-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A211829-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A211829-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A211829-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A211829-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A211829-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A211829-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A211829-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A211829-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A211829-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A211829-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A211829-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A211829-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A211829-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A211829-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A211829-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A211829-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A211829-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A211829-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A211829-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A211829-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A211829-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A211829-002	AB	1	`782e0a99824c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
4367aed1-e488-b72c-d0ec-178a4e054129	Product name	9	20250624
ddc83a74-720a-4975-8550-c4bd979c9094	Product name	1	20221212

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
71610-322-83	2023-01-30	C162847	48780-1	f386c649-ebaf-0266-e053-dadaa90a7c1a	RANOLAZINE EXTENDED-RELEASE TABLETS These highlights do not include all the information needed to use RANOLAZINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for RANOLAZINE EXTENDED-RELEASE TABLETS. RANOLAZINE extended-release tablets, for oral use. Initial U.S. Approval: 2006

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
71610-322-83	RANOLAZINE	3600 in 1 PACKAGE	TABLET, FILM COATED, EXTENDED RE	3600		1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
71610-322-83	EA - Each	71610-322	fe84f8de-d7cc-413b-a60e-fdb132b59de1	1	2019-10-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71610-322	RANOLAZINE TABLET, FILM COATED, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	1	Legacy NDC, 1 package rows	20190831_c842805c-c78d-474e-8a33-c2e828bad800.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
RANOLAZINE	RANOLAZINE	Radha Pharmaceuticals, Inc	38d2833d-44b8-8d46-e063-6394a90a74d8	2026-02-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 211829 application number: ANDA211829
RANOLAZINE	RANOLAZINE	Aphena Pharma Solutions - Tennessee, LLC	45236b7d-3728-1e13-e063-6394a90ad77f	2025-12-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 211829 application number: ANDA211829
RANOLAZINE	RANOLAZINE	ScieGen Pharmaceuticals, Inc	71d50258-75b7-4801-b0f4-c34fe883d57d	2024-12-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 211829 application number: ANDA211829
Ranolazine	RANOLAZINE	Proficient Rx LP	c7ed8234-e6bd-4f19-a1ce-40f272a79036	2024-07-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 211829 application number: ANDA211829
Ranolazine	RANOLAZINE	Proficient Rx LP	989e1688-a0b5-4297-bf91-234de2a0b445	2022-03-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 211829 application number: ANDA211829
Ranolazine	RANOLAZINE	Westminster Pharmaceuticals, LLC	b91e88a0-04d0-4d0d-92d8-966b27a48e29	2021-09-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 211829 application number: ANDA211829

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
A6IEZ5M406	RANOLAZINE	95635-55-5	RANOLAZINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
616749	ranolazine 500 MG 12HR Extended Release Oral Tablet	PSN	c842805c-c78d-474e-8a33-c2e828bad800	1
616749	12 HR ranolazine 500 MG Extended Release Oral Tablet	SCD	c842805c-c78d-474e-8a33-c2e828bad800	1
616749	ranolazine 500 MG 12 HR Extended Release Oral Tablet	SY	c842805c-c78d-474e-8a33-c2e828bad800	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
71610-322-83	71610032283	3600 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE (71610-322-83)	2019-08-13	0000-00-00	No	No	Current